These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18198353)

  • 21. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
    Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice.
    Bullen JW; Bluher S; Kelesidis T; Mantzoros CS
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1079-86. PubMed ID: 17164441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
    Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
    FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2.
    Tsukiyama-Kohara K; Vidal SM; Gingras AC; Glover TW; Hanash SM; Heng H; Sonenberg N
    Genomics; 1996 Dec; 38(3):353-63. PubMed ID: 8975712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.
    Bjursell M; Admyre T; Göransson M; Marley AE; Smith DM; Oscarsson J; Bohlooly-Y M
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E211-20. PubMed ID: 20959533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic administration of BRL 26830A for 9 weeks improves insulin sensitivity but does not prevent weight gain in gold-thioglucose obese mice.
    Bryson JM; Wensley VR; Phuyal JL; Caterson ID; Cooney GJ
    Horm Metab Res; 1999 May; 31(5):317-22. PubMed ID: 10422727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
    Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
    Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
    Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
    Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
    Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
    J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program.
    Andersson U; Henriksson E; Ström K; Alenfall J; Göransson O; Holm C
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E111-21. PubMed ID: 20959531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
    Takahashi N; Qi Y; Patel HR; Ahima RS
    J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo knockdown of p85alpha with an antisense oligonucleotide improves insulin sensitivity in Lep(ob/ob) and diet-induced obese mice.
    Moriarty MW; McCurdy CE; Janssen RC; Shaw T; Leitner JW; Friedman JE; Draznin B
    Horm Metab Res; 2009 Oct; 41(10):757-61. PubMed ID: 19598077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of fat removal on glucose tolerance is depot specific in male and female mice.
    Shi H; Strader AD; Woods SC; Seeley RJ
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1012-20. PubMed ID: 17652151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.
    Moore GB; Pickavance LC; Briscoe CP; Clapham JC; Buckingham RE; Wilding JP
    Diabetes Obes Metab; 2008 Mar; 10(3):251-63. PubMed ID: 18269641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype.
    Oberbauer AM; Stern JS; Johnson PR; Horwitz BA; German JB; Phinney SD; Beermann DH; Pomp D; Murray JD
    Growth Dev Aging; 1997; 61(3-4):169-79. PubMed ID: 9546108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.